single cell, and methylation, as well as a new multimodal data analysis platform. These solutions leverage the power of Illumina's leading NovaSeq X series platform and will enable researchers to ...
As Illumina transitions to its new NovaSeq X platform and implements cost-cutting measures, investors and analysts are closely watching to see if the company can maintain its market leadership and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback